CHD1L and hepatocellular carcinoma: Growing evidences demonstrated that CHD1L was highly expressed in most types of malignancy including hepatocellular carcinoma [10–13], lung cancer [14], breast cancer [15], gastric cancer [16], colorectal cancer [17], bladder cancer [18], and ovarian cancer [19].